Alpha 2.0
Login Register
» Articles » PMID: 39113470

A Bone Tumor-like Chest Wall Mass Lesion with Pathological Rib Fractures Observed 13 years After Lung Stereotactic Body Radiotherapy: A Case Report

Overview
Journal Thorac Cancer
Specialties Oncology
Pulmonary Medicine
Date 2024 Aug 8
PMID 39113470
Authors
Masaki Matsuda
Jiro Ichikawa
Takafumi Komiyama
Kojiro Onohara
Masahide Saito
Hikaru Nemoto
Mizuki Kubota
Hiroshi Onishi
Affiliations
Soon will be listed here.
Abstract

Although stereotactic body radiotherapy (SBRT) is a curative treatment option for stage I non-small cell lung cancer (NSCLC), limited data are available regarding chest wall (CW) toxicities during an extended follow-up of over 10 years. We report an unusual case of a bone tumor-like CW mass lesion with pathological rib fractures observed 13 years after SBRT for peripheral lung cancer. Despite the initial suspicion of radiation-induced sarcoma, a subsequent incisional biopsy revealed no evidence of malignancy, and a definitive diagnosis of osteonecrosis was made. Thus, long-term observation of over 10 years is required to identify late chronic complications following SBRT.

Citing Articles

A bone tumor-like chest wall mass lesion with pathological rib fractures observed 13 years after lung stereotactic body radiotherapy: A case report.

Matsuda M, Ichikawa J, Komiyama T, Onohara K, Saito M, Nemoto H Thorac Cancer. 2024; 15(26):1912-1916.

PMID: 39113470 PMC: 11462948. DOI: 10.1111/1759-7714.15419.

References
1.
Mark R, Poen J, Tran L, Fu Y, Selch M, Parker R . Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994; 73(10):2653-62. DOI: 10.1002/1097-0142(19940515)73:10<2653::aid-cncr2820731030>3.0.co;2-g. View
2.
Chipko C, Ojwang J, Gharai L, Deng X, Mukhopadhyay N, Weiss E . Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy. Pract Radiat Oncol. 2019; 9(3):e338-e346. PMC: 6511403. DOI: 10.1016/j.prro.2019.01.012. View
3.
Chang J, Mehran R, Feng L, Verma V, Liao Z, Welsh J . Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. 2021; 22(10):1448-1457. PMC: 8521627. DOI: 10.1016/S1470-2045(21)00401-0. View
4.
Khanna L, Prasad S, Yedururi S, Parameswaran A, Marcal L, Sandrasegaran K . Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings. Radiographics. 2021; 41(3):876-894. DOI: 10.1148/rg.2021200171. View
5.
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K . Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?. Int J Radiat Oncol Biol Phys. 2010; 81(5):1352-8. DOI: 10.1016/j.ijrobp.2009.07.1751. View